Our mission is to be recognised as the leading urologist focused speciality pharmaceutical business in Europe.
The urology market is highly specialist driven and our focus is on developing an attractive portfolio of products owned by the Company, such as Plenaxis® and Mitem®, as well as being a partner of choice for others looking to maximize the European sales of their products.
Our team is experienced in bringing products through on to the European market. We have direct experience of all aspects required to drive a successful specialty pharmaceutical business:
- dealing with the European regulators to gain the appropriate marketing authorisations and approvals
- developing attractive, pan-European pricing strategies
- negotiating products through the differing reimbursement processes
- successful, multi-country product launches
- managing production, packaging and distribution partners
- managing local commercial partners in out-licensed territories
- acquisition of attractive, late stage products
We are seeking products that are in phase III, registration or in-market.
OUR TEAM'S
TRACK RECORD
In total, members of the team have:
- managed numerous clinical trials in Europe
- made regulatory submissions, including both centralised and mutual recognition procedures
- run the European pricing system for a major global pharmaceutical company
- established and run companies in all the major European countries and invested in more than 40 healthcare companies.
Can't find what you're looking for? Try our Site Map
site design: www.message-design.co.uk
